Atlas Trials

Nader Sanai

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nader Sanai

RecordFirmDate
BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors (NCT07485049)Nader Sanai2026-05-07
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases (NCT07268053)Nader Sanai2026-02-11
Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas (NCT06824662)Nader Sanai2025-09-04
Clinical Trial of BMS-986504 in Recurrent GBM Patients (NCT06883747)Nader Sanai2025-04-28
Abemaciclib in Newly Diagnosed Meningioma Patients (NCT05940493)Nader Sanai2025-03-24
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG (NCT05773326)Nader Sanai2023-05-15
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients (NCT05182905)Nader Sanai2022-05-27
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma (NCT05076513)Nader Sanai2021-10-29
Study of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma (NCT04559685)Nader Sanai2021-03-15
Study of Pamiparib in Newly Diagnosed and rGBM (NCT04614909)Nader Sanai2021-01-11
Infigratinib in Recurrent High-Grade Glioma Patients (NCT04424966)Nader Sanai2020-07-21
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients (NCT04391595)Nader Sanai2020-07-11

Track Nader Sanai automatically

Every clearance here is in the API, with alerts when new ones post.